ENTITY ocrelizumab

ocrelizumab

PulseAugur coverage of ocrelizumab — every cluster mentioning ocrelizumab across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

1

1 over 90d

TIER MIX · 90D

TOPICS

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

TOOL · CL_118101 · Jun 30 · 04:00

New MCIDs for smartphone gait measures in multiple sclerosis established

Researchers have established minimal clinically important differences (MCIDs) for gait measures derived from smartphones in individuals with multiple sclerosis (MS). These MCIDs, determined using an anchor-based approac…